Câncer do ovário, trompa de Falópio

Coelho, Francisco Ricardo Gualda; Pinto, Gabriel Lowdes de Souza; Sanches, Solange Moraes; Guimarães, Andréa Paiva Gadelha; Hanriott, Rodrigo de Morais; Costa, Ronaldo Lúcio Rangel; Santin, Andréa; Bezerra, Adriana Pinheiro.
In. Kowalski, Luiz Paulo; Guimarães, Gustavo Cardoso; Salvajoli, João Victor; Feher, Olavo; Antoneli, Célia Beatriz Gianotti. Manual de Condutas Diagnósticas e Terapêuticas em Oncologia. São Paulo, Âmbito Editores, 3 ed; 2006. p.731-742.
Monografía en Portugués | LILACS | ID: lil-487866

Documentos relacionados

  1. The Significance of Radiotherapy in Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis.
  2. Adjuvant Treatment of Early Ovarian Clear Cell Carcinoma: A Population-Based Study of Whole Abdominal Versus Pelvic Nodal Radiotherapy.
  3. Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC).
  4. Immunotherapy for ovarian cancer: recent advances and perspectives.
  5. [Case of Long-Term Response to Radiotherapy for Intramedullary Spinal Cord Metastasis from Ovarian Cancer after Surgery].
  6. Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups.
  7. Recurrent Ovarian Cancer: The Role of Radiation Therapy.
  8. Persistent response of an ovarian cancer patient after a short-term single-agent immunotherapy: a case report.
  9. Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
  10. Locally produced autoantibodies in cancer.